182 related articles for article (PubMed ID: 24047462)
1. B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.
Sundaramoorthy S; Ryu MS; Lim IK
Cell Commun Signal; 2013 Sep; 11():69. PubMed ID: 24047462
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
3. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
5. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
6. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
[TBL] [Abstract][Full Text] [Related]
7. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
8. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression.
Cho SJ; Park JW; Kang JS; Kim WH; Juhnn YS; Lee JS; Kim YH; Ko YS; Nam SY; Lee BL
Cancer Sci; 2008 Jun; 99(6):1117-24. PubMed ID: 18384434
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB.
Rojo AI; Salinas M; Martín D; Perona R; Cuadrado A
J Neurosci; 2004 Aug; 24(33):7324-34. PubMed ID: 15317858
[TBL] [Abstract][Full Text] [Related]
11. TIS21
Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation of phosphatidylinositol 3-kinase/Akt/nuclear factor kappaB signaling mediates G protein-coupled delta-opioid receptor gene expression.
Chen YL; Law PY; Loh HH
J Biol Chem; 2006 Feb; 281(6):3067-74. PubMed ID: 16316997
[TBL] [Abstract][Full Text] [Related]
13. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
15. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
[TBL] [Abstract][Full Text] [Related]
17. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
[TBL] [Abstract][Full Text] [Related]
18. IkappaBalpha (inhibitory kappaBalpha) identified as labile repressor of MnSOD (manganese superoxide dismutase) expression.
Kiningham KK; Daosukho C; St Clair DK
Biochem J; 2004 Dec; 384(Pt 3):543-9. PubMed ID: 15330761
[TBL] [Abstract][Full Text] [Related]
19. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
20. Wortmannin-sensitive pathway is required for insulin-stimulated phosphorylation of inhibitor kappaBalpha.
Pandey SK; He HJ; Chesley A; Juhaszova M; Crow MT; Bernier M
Endocrinology; 2002 Feb; 143(2):375-85. PubMed ID: 11796489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
